Clinical and Vaccine Immunology : Cvi
Overview
Clinical and Vaccine Immunology : Cvi is a scientific journal, published by American Society for Microbiology since 2006 in English. The journal's country of origin is United States and its primary focus areas are pathology and allergy & immunology.
Details
Details
Abbr.
Clin Vaccine Immunol
Publisher
American Society for Microbiology
Start
2006
End
2017
Frequency
Monthly
p-ISSN
1556-6811
e-ISSN
1556-679X
Country
United States
Language
English
Specialties
Pathology
Allergy & Immunology
Allergy & Immunology
Recent Articles
1.
Nishimori A, Konnai S, Okagawa T, Maekawa N, Goto S, Ikebuchi R, et al.
Clin Vaccine Immunol
. 2018 May;
24(12).
PMID: 29741849
No abstract available.
2.
Schmink S, Kruszon-Moran D, Dollard S, Lanzieri T
Clin Vaccine Immunol
. 2017 Nov;
24(11).
PMID: 29109126
No abstract available.
3.
4.
Pasetti M, Douglas S, Plaeger S
Clin Vaccine Immunol
. 2017 Oct;
24(12).
PMID: 29070528
(CVI) will merge with the American Society for Microbiology (ASM) open-access journal in January 2018. We commemorate this transition by exploring the history of CVI and that of its predecessor,...
5.
Zuverink M, Barbieri J
Clin Vaccine Immunol
. 2017 Oct;
24(12).
PMID: 29046310
Select agents (SA) pose unique challenges for licensing vaccines and therapies. In the case of toxin-mediated diseases, HHS assigns guidelines for SA use, oversees vaccine and therapy development, and approves...
6.
Dharmasena M, Osorio M, Takeda K, Stibitz S, Kopecko D
Clin Vaccine Immunol
. 2017 Oct;
24(12).
PMID: 29046309
We have been exploring the use of the live attenuated serovar Typhi Ty21a vaccine strain as a versatile oral vaccine vector for the expression and delivery of multiple foreign antigens,...
7.
Schleiss M, Permar S, Plotkin S
Clin Vaccine Immunol
. 2017 Oct;
24(12).
PMID: 29046308
A vaccine against congenital human cytomegalovirus (CMV) infection is a major public health priority. Congenital CMV causes substantial long-term morbidity, particularly sensorineural hearing loss (SNHL), in newborns, and the public...
8.
Toth 4th R, Angalakurthi S, Van Slyke G, Vance D, Hickey J, Joshi S, et al.
Clin Vaccine Immunol
. 2017 Oct;
24(12).
PMID: 29046307
RiVax is a promising recombinant ricin toxin A subunit (RTA) vaccine antigen that has been shown to be safe and immunogenic in humans and effective at protecting rhesus macaques against...
9.
King T, Shanley C, Guo Z, Bellgrau D, Rodell T, Furney S, et al.
Clin Vaccine Immunol
. 2017 Oct;
24(12).
PMID: 29046306
As yet, very few vaccine candidates with activity in animals against infection have been tested as therapeutic postexposure vaccines. We recently described two pools of mycobacterial proteins with this activity,...
10.
Changsom D, Jiang L, Lerdsamran H, Iamsirithaworn S, Kitphati R, Pooruk P, et al.
Clin Vaccine Immunol
. 2017 Oct;
24(12).
PMID: 29021304
The kinetics, longevity, and breadth of antibodies to influenza virus neuraminidase (NA) in archival, sequential serum/plasma samples from influenza A virus (IAV) H5N1 infection survivors and from patients infected with...